| Identification | |
| Name: | Calcifediol anhydrous |
| Synonyms: | 9,10-Secocholesta-5,7,10(19)-triene-3,25-diol,(3b,5Z,7E)- (9CI);9,10-Secocholesta-5,7,10(19)-triene-3b,25-diol (8CI);25-HCC;25-Hydroxycholecalciferol;25-Hydroxyvitamin D;25-Hydroxyvitamin D3;5,6-cis-25-Hydroxyvitamin D3;Calcidiol;1H-Indene-1-pentanol,4-[(2Z)-2-[(5S)-5-hydroxy-2-methylenecyclohexylidene]ethylidene]octahydro-a,a,e,7a-tetramethyl-, (eR,1R,3aS,4E,7aR)-;Calderol;Cholecalciferol, 25-hydroxy-;Didrogyl;Hidroferol;Hy-D;Ro 8-8892;Rovimix Hy-D;U 32070E; |
| CAS: | 19356-17-3 |
| EINECS: | 242-990-9 |
| Molecular Formula: | C27H44O2 |
| Molecular Weight: | 400.64 |
| InChI: | InChI=1S/C27H44O2/c1-19-10-13-23(28)18-22(19)12-11-21-9-7-17-27(5)24(14-15-25(21)27)20(2)8-6-16-26(3,4)29/h11-12,20,23-25,28-29H,1,6-10,13-18H2,2-5H3/b21-11+,22-12-/t20-,23+,24-,25+,27-/m1/s1 |
| Molecular Structure: |  |
| Properties | |
| Transport: | UN 2811 6 |
| Density: | 1.01 g/cm3 |
| Specification: |
Calcifediol (CAS NO.19356-17-3) is also named as (5Z,7E)-9,10-Seco-5,7,10(19)-cholestatrien-3beta,25-diol ; 25-Hydroxycholescalciferol ; 25-Hydroxyvitamin D ; 25-Hydroxyvitamin D3 ; 5,6-cis-25-Hydroxyvitamin D3 ; 5,6-trans-25-Hydroxycholescalciferol ; 5,6-trans-9,10-Seco-5,7,10(19)-cholestatrien-3beta,25-diol ; 9,10-Secocholesta-5,7,10(19)-triene-3beta,25-diol ; Calcidiol ; Calcifediolum ; Calcifediolum [INN-Latin] ; Calcifidiol ; Cholecalciferol, 25-hydroxy- ; Delakmin ; Didrogyl ; Hidroferol ; Ro 8-8892 ; Rovimix Hy-D ; U 32070 E ; UNII-T0WXW8F54E . It is the principal circulating form of vitamin D3. |
| Storage Temperature: | −20°C |
| Usage: |
In medicine, the Calcifediol (CAS NO.19356-17-3) blood test is used to determine how much vitamin D is in the body. |
| Safety Data | |
| Hazard Symbols |
T+: Very toxic
|
 |
|
